What is the optimal treatment for Duchenne muscular dystrophy in the MENA region? Find out in this paper published by Neurodegenerative Disease Management.
Jenny Straiton explores the miniature world of organoids and discusses how these small models are making big changes in the world of neurological research.
In this commentary from Future Neurology, the authors overview and compare cerebral organoids and other 3D aggregated cell cultures.
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
In this review from Biomarkers in Medicine, researchers demonstrate that PARK7 and NDKA could present more clinical important information as biomarkers for management of stroke disease.
Take a look behind the scenes of a recent CNS Oncology paper as we ask the authors about the Nativis Voyager® for the treatment of glioblastoma.
In this review article from Biomarkers in Medicine, researchers explore the current application of blood-based markers to assess amyloid-β pathology.
In this research article from Biomarkers in Medicine, researchers determine if serum levels of tau and BDNF can be used as severity biomarkers in multiple sclerosis.
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
